β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease.
Arif E, Medunjanin D, Solanki A, Zuo X, Su Y, Dang Y, Winkler B, Lerner K, Kamal AI, Palygin O, Cornier MA, Wolf BJ, Hunt KJ, Lipschutz JH.
Arif E, et al. Among authors: medunjanin d.
Am J Physiol Renal Physiol. 2024 Jan 1;326(1):F20-F29. doi: 10.1152/ajprenal.00254.2023. Epub 2023 Nov 2.
Am J Physiol Renal Physiol. 2024.
PMID: 37916289